These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23436046)

  • 1. Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantation.
    Li J; Liu J; Huang B; Zheng D; Chen M; Zhou Z; Xu D; Zou W
    Tumour Biol; 2013 Jun; 34(3):1723-8. PubMed ID: 23436046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant.
    Li J; Huang B; Li Y; Zheng D; Zhou Z; Liu J
    Leuk Lymphoma; 2015 Jun; 56(6):1710-7. PubMed ID: 25098429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma.
    Park H; Kim DY; Kim SJ; Chung H; Cho H; Jang JE; Cheong JW; Min YH; Song JW; Kim JS
    Cancer Res Treat; 2018 Oct; 50(4):1121-1129. PubMed ID: 29198097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
    Varma A; Biritxinaga L; Saliba RM; Stich M; Jauch SF; Afrough A; Honhar M; Popat UR; Shafi MA; Shah N; Bashir Q; Dinh Y; Hosing C; Champlin RE; Qazilbash MH
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):581-587. PubMed ID: 28063964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy.
    Lee JY; Lim SH; Lee MY; Kim H; Sinn DH; Gwak GY; Choi MS; Lee JH; Jung CW; Jang JH; Kim WS; Kim SJ; Kim K
    Liver Int; 2015 Nov; 35(11):2363-9. PubMed ID: 25832927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
    Uhm JE; Kim K; Lim TK; Park BB; Park S; Hong YS; Lee SC; Hwang IG; Koh KC; Lee MH; Ahn JS; Kim WS; Jung CW; Kang WK
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients.
    Ceneli O; Ozkurt ZN; Acar K; Rota S; Aki SZ; Yeğin ZA; Yağci M; Ozenirler S; Sucak GT
    World J Gastroenterol; 2010 Apr; 16(14):1765-71. PubMed ID: 20380010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation.
    Schubert A; Michel D; Mertens T
    BMC Infect Dis; 2013 May; 13():223. PubMed ID: 23679074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
    J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
    Matsue K; Aoki T; Odawara J; Fujiwara H; Iwama K; Kimura S; Yamakura M; Takeuch M
    Eur J Haematol; 2009 Oct; 83(4):357-64. PubMed ID: 19508685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT.
    Viganò M; Vener C; Lampertico P; Annaloro C; Pichoud C; Zoulim F; Facchetti F; Poli F; Scalamogna M; Deliliers GL; Colombo M
    Bone Marrow Transplant; 2011 Jan; 46(1):125-31. PubMed ID: 20383209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation.
    Lau GK; Leung YH; Fong DY; Au WY; Kwong YL; Lie A; Hou JL; Wen YM; Nanj A; Liang R
    Blood; 2002 Apr; 99(7):2324-30. PubMed ID: 11895763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea.
    Jun CH; Kim BS; Oak CY; Lee DH; Cho E; Cho SB; Choi SK; Park CH; Joo YE; Lee JJ; Kim HJ
    Hepatol Int; 2017 Jan; 11(1):87-95. PubMed ID: 27351765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of hepatitis B virus infection in multiple myeloma.
    Huang B; Li J; Zhou Z; Zheng D; Liu J; Chen M
    Leuk Lymphoma; 2012 Feb; 53(2):270-4. PubMed ID: 21823833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.
    Buzo BF; Ramos JF; Marques Rossetti RA; Salles N; Mendrone-Júnior A; Rocha V; de Seixas Santos Nastri AC
    Transpl Infect Dis; 2020 Apr; 22(2):e13243. PubMed ID: 31901206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of antiviral prophylaxis in HBsAg-negative, anti-HBc positive patients undergoing hematopoietic stem cell transplantation.
    Yoo JJ; Cho EJ; Cho YY; Lee M; Lee DH; Cho Y; Lee JH; Yu SJ; Yoon SS; Yoon JH; Kim YJ
    Liver Int; 2015 Dec; 35(12):2530-6. PubMed ID: 26053357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.